BarnaM., UomoI., and PastorelloM. “Oral Agents for Treatment of Patients With Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?”. JOP. Journal of the Pancreas, Vol. 14, no. 1, Jan. 2013, pp. 102-4, doi:10.6092/1590-8577/1354.